By Jon Rappoport ——Bio and Archives--January 13, 2022
American Politics, News | CFP Comments | Reader Friendly | Subscribe | Email Us
“Potential cross reactivity of the InteliSwab COVID-19 Rapid Test with COVID-19 vaccines or therapeutics has not been evaluated.”In the medical community, the term “cross reactivity” is universally understood. It means: a test designed to detect whether X is present in a person’s body is, in fact, detecting Y, an entirely irrelevant item, BUT is mistakenly calling it X. For example, a person had three drinks the night before his test, and the test then came up positive for the presence of a germ, when actually the test was reacting to the alcohol in the drinks. And in this document I just quoted, the manufacturer readily admits it hasn’t looked into the possibility that the COVID test is reacting to the COVID VACCINE and then mistakenly stating the vaccinated person has THE VIRUS in his body. So the question is: why hasn’t the manufacturer looked into this cross reactivity issue? The document shows tests for all sorts of other possible cross reactivity. And the next question is: how can the FDA grant emergency use authorization for this rapid test, when cross reactivity with the vaccine hasn’t been explored?
View Comments
The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free NoMoreFakeNews emails hereor his free OutsideTheRealityMachine emails here.